File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: ‘The Double-Edged Sword’ – An hypothesis for Covid-19-induced salivary biomarkers

Title‘The Double-Edged Sword’ – An hypothesis for Covid-19-induced salivary biomarkers
Authors
KeywordsCOVID-19 pandemic
Saliva biomarkers
SARS-CoV-2
Issue Date2020
PublisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/mehy
Citation
Medical Hypotheses, 2020, v. 143, p. article no. 110124 How to Cite?
AbstractUtilising biomarkers for COVID-19 diagnosis, prediction of treatment response and overall prognostication have been investigated recently. However, these ventures have only considered the use of blood-based molecular markers. Saliva is another biofluid that warrants being applied in similar fashion with major advantages that centres on its non-invasive and repeatable collection as well as cost-efficiency. To this end, this article presents a hypothesis for the sources of biomarkers useful clinically for COVID-19 disease outcome estimation and identify the likely implications of their detection in saliva.
Persistent Identifierhttp://hdl.handle.net/10722/284786
ISSN
2023 Impact Factor: 2.1
2023 SCImago Journal Rankings: 0.587
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorADEOYE, J-
dc.contributor.authorThomson, P-
dc.date.accessioned2020-08-07T09:02:36Z-
dc.date.available2020-08-07T09:02:36Z-
dc.date.issued2020-
dc.identifier.citationMedical Hypotheses, 2020, v. 143, p. article no. 110124-
dc.identifier.issn0306-9877-
dc.identifier.urihttp://hdl.handle.net/10722/284786-
dc.description.abstractUtilising biomarkers for COVID-19 diagnosis, prediction of treatment response and overall prognostication have been investigated recently. However, these ventures have only considered the use of blood-based molecular markers. Saliva is another biofluid that warrants being applied in similar fashion with major advantages that centres on its non-invasive and repeatable collection as well as cost-efficiency. To this end, this article presents a hypothesis for the sources of biomarkers useful clinically for COVID-19 disease outcome estimation and identify the likely implications of their detection in saliva.-
dc.languageeng-
dc.publisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/mehy-
dc.relation.ispartofMedical Hypotheses-
dc.subjectCOVID-19 pandemic-
dc.subjectSaliva biomarkers-
dc.subjectSARS-CoV-2-
dc.title‘The Double-Edged Sword’ – An hypothesis for Covid-19-induced salivary biomarkers-
dc.typeArticle-
dc.identifier.emailThomson, P: thomsonp@hku.hk-
dc.identifier.authorityThomson, P=rp02327-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1016/j.mehy.2020.110124-
dc.identifier.pmid32721813-
dc.identifier.pmcidPMC7372268-
dc.identifier.scopuseid_2-s2.0-85088402103-
dc.identifier.hkuros311825-
dc.identifier.volume143-
dc.identifier.spagearticle no. 110124-
dc.identifier.epagearticle no. 110124-
dc.identifier.isiWOS:000577511800131-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0306-9877-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats